Teriparatide (C181H291N55O51S2) – 600mcg per vial

Clinical Test Expectation – Teriparatide – 600mcg – Human Subjects : Treats Osteoporosis. Stimulates the formation of new bone and leads to increased bone mineral density
Strength – 600mcg per vial

Introduction

Teriparatide injection is used to treat osteoporosis in postmenopausal women who are at high risk for bone fracture. It reduces the risk of having bone and spine fracture in postmenopausal women with osteoporosis. This injection is also used to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for bone fracture or cannot use other osteoporosis treatments. This peptide is also used to treat osteoporosis caused by steroid (glucocorticoid) medicine in men and women who are at high risk for bone fracture or cannot use other osteoporosis treatments.

Teriparatide is a synthetic form of the natural human parathyroid hormone. This medicine helps your body to form new bone, increase bone mineral density and bone strength. As a result, it reduces the chance of getting a fracture (broken bone).

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/